Smruthi Organics (BOM:540686) Cyclically Adjusted Revenue per Share: ₹129.28 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540686 Smruthi Organics Ltd BOM:540686
64 GF Score
Price ₹119.65
GF Value ₹105.76
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Smruthi Organics Cyclically Adjusted Revenue per Share?

Smruthi Organics BOM:540686 +4.04% 64 Cyclically Adjusted Revenue per Share is ₹129.28 as of Mar. 2026. GuruFocus rates BOM:540686 with a GF Score™ of 64/100 and a GF Value™ of ₹105.76 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Smruthi Organics's adjusted revenue per share for the three months ended in Mar. 2026 was ₹25.354. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹129.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Smruthi Organics's average Cyclically Adjusted Revenue Growth Rate was 3.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Smruthi Organics was 2.90% per year. The lowest was -0.50% per year. And the median was 0.00% per year.

As of today (2026-08-06), Smruthi Organics's current stock price is ₹119.65. Smruthi Organics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹129.28. Smruthi Organics's Cyclically Adjusted PS Ratio of today is 0.93.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Smruthi Organics was 3.10. The lowest was 0.69. And the median was 1.28.


Smruthi Organics  (BOM:540686) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Smruthi Organics's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=119.65/129.28
=0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Smruthi Organics was 3.10. The lowest was 0.69. And the median was 1.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Smruthi Organics Cyclically Adjusted Revenue per Share Related Terms


Smruthi Organics Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Smruthi Organics's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Smruthi Organics Cyclically Adjusted Revenue per Share Chart

Smruthi Organics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 127.09 118.68 121.28 125.15 129.28

Smruthi Organics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 125.15 126.24 128.78 129.07 129.28

BOM:540686 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smruthi Organics Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Smruthi Organics's Cyclically Adjusted PS Ratio falls into.


BOM:540686
64GF Score
Smruthi Organics Ltd BOM:540686
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Smruthi Organics Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Smruthi Organics's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=25.354/164.2724*164.2724
=25.354

Current CPI (Mar. 2026) = 164.2724.

Smruthi Organics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 17.227 105.961 26.707
201609 15.798 105.961 24.492
201612 16.335 105.196 25.508
201703 19.140 105.196 29.889
201706 14.935 107.109 22.906
201709 23.492 109.021 35.398
201712 18.902 109.404 28.382
201803 26.429 109.786 39.545
201806 24.721 111.317 36.481
201809 25.171 115.142 35.911
201812 33.984 115.142 48.485
201903 33.847 118.202 47.039
201906 28.372 120.880 38.557
201909 33.081 123.175 44.118
201912 26.898 126.235 35.003
202003 24.604 124.705 32.411
202006 25.628 127.000 33.149
202009 32.197 130.118 40.648
202012 27.580 130.889 34.614
202103 23.203 131.771 28.926
202106 26.953 134.084 33.021
202109 25.411 135.847 30.728
202112 30.649 138.161 36.442
202203 35.432 138.822 41.928
202206 24.987 142.347 28.836
202209 36.796 144.661 41.784
202212 27.891 145.763 31.433
202303 31.772 146.865 35.538
202306 30.446 150.280 33.281
202309 25.881 151.492 28.064
202312 20.486 152.924 22.006
202403 33.948 153.035 36.441
202406 23.934 155.789 25.237
202409 25.784 157.882 26.828
202412 27.226 158.323 28.249
202503 33.311 157.552 34.732
202506 16.645 159.755 17.116
202509 27.659 162.289 27.997
202512 19.455 163.281 19.573
202603 25.354 164.272 25.354

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹129.28 mean?
Smruthi Organics (BOM:540686) has a Cyclically Adjusted Revenue per Share of ₹129.28 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Smruthi Organics and its competitors.
Is Smruthi Organics' Cyclically Adjusted Revenue per Share too high?
Smruthi Organics' current Cyclically Adjusted Revenue per Share is ₹129.28. Overall, Smruthi Organics has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Smruthi Organics' Cyclically Adjusted Revenue per Share compare to ZTS?
Smruthi Organics' Cyclically Adjusted Revenue per Share of ₹129.28 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Smruthi Organics and its competitors. Smruthi Organics's current Cyclically Adjusted Revenue per Share is ₹129.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Smruthi Organics stock overvalued right now?
Based on GuruFocus' analysis, Smruthi Organics (BOM:540686) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹105.76, compared to a current price of ₹119.65 — trading 13.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹129.28. Smruthi Organics' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Smruthi Organics (BOM:540686), the current Cyclically Adjusted Revenue per Share is ₹129.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Smruthi Organics (BOM:540686) Overvalued in 2026?

Based on GuruFocus' analysis, Smruthi Organics stock appears to be overvalued. The current stock price of ₹119.65 is trading 13.1% above its estimated GF Value™ of ₹105.76. GuruFocus considers Smruthi Organics to be Modestly Overvalued.

Key valuation signals for BOM:540686:

  • Cyclically Adjusted Revenue per Share: ₹129.28
  • GF Value™: ₹105.76 vs. price of ₹119.65 (13.1% above fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the BOM:540686 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Smruthi Organics Business Description

Address Railway Lines, 165-A, 1st Floor, Balaji Bhavan, Solapur, MH, IND, 413001
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium, and many more. It has two reportable business segments: Bulk Drugs and Drugs Intermediates (API), and Formulation. It generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment. Geographically, the company generates maximum revenue from outside India through exports, and the rest from its business within India.
64GF Score

Get the complete analysis for BOM:540686

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹119.65
Price
₹105.76
GF Value